Fruth Pharmacy #13 Pharmacy Location: 12803 Winfield Rd, Winfield, West Virginia 25213 Phone: (304) 586-3088 |
News Archive
The federal government on Tuesday extended a Medicaid waiver in Massachusetts, which was first implemented as part of then-Gov. Mitt Romney's healthcare overhaul. The waiver will now run through 2014. It is focused primarily on efforts to improve the cost and quality of the Medicaid program and better coordinate care. The waiver provides incentives for hospitals to improve their efforts to integrate their services.
Imaging amino acid transporters with positron emission tomography/computed tomography (PET/CT) has been shown to significantly alter intended management plans for patients with brain tumors, according to research in the March issue of The Journal of Nuclear Medicine.
Elusys Therapeutics, Inc., a privately-held biopharmaceutical company, announced today that it has been awarded a second contract year of funding valued at $40.6 million for the advanced development of Anthim for the prevention and treatment of anthrax infection following a biowarfare attack. This funding is in addition to $16.8 million already received under this contract and is part of a potential five year contract award totaling up to $143 million if all options are exercised by the Government.
The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the first anti-PD-1 immunotherapy in the United States for treatment of advanced and unresectable malignant melanoma.
A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests.
› Verified 4 days ago